Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients

Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients

Saved in:

Bibliographic Details
Main Authors:	Lixuan Qian, Ziteng Wang, Mary F. Paine, Eric Chun Yong Chan, Zhu Zhou
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	CPT: Pharmacometrics & Systems Pharmacology
Online Access:	https://doi.org/10.1002/psp4.13241
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
by: Lixuan Qian, et al.
Published: (2025-01-01)

Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy
by: Farzaneh Salem, et al.
Published: (2024-11-01)

Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach
by: Juyoung Khwarg, et al.
Published: (2024-12-01)

Application of Physiologically Based Pharmacokinetic Models in Chemical Risk Assessment
by: Moiz Mumtaz, et al.
Published: (2012-01-01)

Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
by: Jing Ai, et al.
Published: (2024-10-01)

The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment
by: Xavier J. H. Pepin, et al.
Published: (2024-12-01)

Corrigendum: Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
by: Jing Ai, et al.
Published: (2024-11-01)

A physiologically-based pharmacokinetic model for the antibiotic ertapenem
by: Michele L. Joyner, et al.
Published: (2015-09-01)

Predicting Pharmacokinetics of Active Constituents in <i>Spatholobi caulis</i> by Using Physiologically Based Pharmacokinetic Models
by: Xiaoyan Liu, et al.
Published: (2024-12-01)

Prediction of SPT-07A Pharmacokinetics in Rats, Dogs, and Humans Using a Physiologically-Based Pharmacokinetic Model and In Vitro Data
by: Xiaoqiang Zhu, et al.
Published: (2024-12-01)

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin
by: Cameron Humerickhouse, et al.
Published: (2024-11-01)

A tutorial on physiologically based pharmacokinetic approaches in lactation research
by: Amita Pansari, et al.
Published: (2024-11-01)

Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs
by: Jérémy Béguin, et al.
Published: (2024-12-01)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024-11-01)

Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
by: Sara Peribañez-Dominguez, et al.
Published: (2025-01-01)

Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review
by: Iria Varela-Rey, et al.
Published: (2024-12-01)

Physiologically-based pharmacokinetic modeling of enantioselective hydroxychloroquine kinetics and impact of genetic polymorphisms
by: Gabriella de Souza Gomes Ribeiro, et al.
Published: (2025-01-01)

Postpartum changes in maternal physiology and milk composition: a comprehensive database for developing lactation physiologically-based pharmacokinetic models
by: Neel Deferm, et al.
Published: (2025-02-01)

Simultaneous Determination of Five Components of Chaihu-Shugan-San in Beagle Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study after a Single Dose of Chaihu-Shugan-San
by: Yong-liang Zhu, et al.
Published: (2020-01-01)

Population Pharmacokinetics and Dosing Optimization of Norvancomycin for Chinese Patients with Community-Acquired Pneumonia
by: Li Y, et al.
Published: (2024-12-01)

Peritoneal Nebulization of Ropivacaine during Laparoscopic Cholecystectomy: Dose Finding and Pharmacokinetic Study
by: Massimo Allegri, et al.
Published: (2017-01-01)

Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT—Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment
by: Michael D. Taylor, et al.
Published: (2012-01-01)

Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models
by: Abdulkarim Najjar, et al.
Published: (2024-12-01)

Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAs
by: Emilie Langeskov Salim, et al.
Published: (2025-01-01)

Imaging Dose-dependent Pharmacokinetics of an RGD-Fluorescent Dye Conjugate Targeted to αβ Receptor Expressed in Kaposi's Sarcoma
by: Sunkuk Kwon, et al.
Published: (2005-04-01)

Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment
by: Fan Mou, et al.
Published: (2024-12-01)

Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension
by: Lene Nygaard Axelsen, et al.
Published: (2024-12-01)

External Validation of the Population Pharmacokinetic Models of Amisulpride and Remedial Strategies for Delayed or Missed Doses
by: Yan D, et al.
Published: (2024-12-01)

Etodolac Single Dose Metabolic Profile Elucidation: Pharmacokinetics and Adverse Events in Healthy Volunteers
by: Karen Sánchez-Luquez, et al.
Published: (2025-01-01)

Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection
by: Zhang R, et al.
Published: (2024-12-01)

Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
by: Soyoung Lee, et al.
Published: (2024-12-01)

Physiologically Based Pharmacokinetic and Physiologically Based Biopharmaceutic models research in Latin America: A regional level bibliometric analysis, 2011-2023
by: Marx Ribeiro, et al.
Published: (2025-01-01)

Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro Ki and pharmacokinetic parameters?
by: Toshiaki Tsuchitani, et al.
Published: (2024-12-01)

Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
by: Zhuan Yang, et al.
Published: (2024-11-01)

The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
by: Baralee Punyawudho, et al.
Published: (2025-01-01)

Prediction of drug-drug interactions in clozapine combination therapy based on physiologically based pharmacokinetic model
by: MOU Fan, et al.
Published: (2024-11-01)

Physiology‐based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab
by: Pradeep Sharma, et al.
Published: (2025-01-01)

Optimal dose of mivacurium for laser-assisted laryngeal microsurgery: a pharmacokinetic study using closed-loop target-controlled infusion
by: Yan Liu, et al.
Published: (2024-11-01)

A prospective study to evaluate high dose daptomycin pharmacokinetics and pharmacodynamics in spp. infective endocarditis
by: Simona De Gregori, et al.
Published: (2025-01-01)

Assessment of pharmacokinetics and tolerability following single‐dose administration of molnupiravir in participants with hepatic or renal impairment
by: Kelly E. Duncan, et al.
Published: (2024-12-01)